FDA Investigator

Esther A Ofori

Latest inspection on record: O'Fallon, United States, May 2026 · records back to 2017

BiologicsFoods & CosmeticsAnimal Drugs & Feeds

FDA inspection record · Last updated July 12, 2026

Overview

  • 144 inspections across 140 sites are on record.
  • 137 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2026-05-21.

At a glance

Inspections

144

Sites

140

Observations

137

Career since

Mar 2017

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
CSL Plasma Inc.21 May 2026Biologics
Biomat USA Inc23 Apr 2026Biologics
BioLife Plasma Services LP14 Apr 2026Biologics
Dendreon Pharmaceuticals LLC25 Mar 2026BiologicsView 483 →
Embryology Laboratory, LLC23 Feb 2026Biologics

Sites inspected

CSL Plasma Inc.O'Fallon, United States1 insp.
Biomat USA IncIndependence, United States1 insp.
BioLife Plasma Services LPFairview Heights, United States1 insp.
Dendreon Pharmaceuticals LLCSeal Beach, United States1 insp.
Embryology Laboratory, LLCFrontenac, United States1 insp.

Co-investigators

Investigators who share inspections with this person.

David A Moore2 shared

Full investigator report

Get the verbatim findings behind Esther A Ofori's 137 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site